TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Manufacture of vaccine clinical lot

Research and development services and related consultancy services
Yorkshire & Humber (UKE21)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: UNIVERSITY OF YORK: "Manufacture of vaccine clinical lot". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityUNIVERSITY OF YORKScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: UNIVERSITY OF YORK
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for UNIVERSITY OF YORK. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
100% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 9 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUNIVERSITY OF YORK
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published1 Jun 2022, 12:36 BST
Last source update1 Jun 2022, 12:36 BST
Recurring procurementNot published
ClassificationResearch and development services and related consultancy services
Delivery area
Yorkshire & Humber (UKE21)
OCIDocds-h6vhtk-03428e
What is being bought
Manufacture of a clinical lot of leishmaniasis vaccine
What changed
From the official release history
  1. Status changed to complete
    1 Jun 2022, 12:36 BST
  2. Official notice release published
    1 Jun 2022, 12:36 BST
  3. Buyer information updated
    1 Jun 2022, 12:36 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Manufacture of a clinical lot of leishmaniasis vaccine covering; Compatability study: Production and Testing of Tox Lot, Clinical Material: GMP Production and Testing of Drug Substance (DS), Clinical Material: Production and Testing of Drug Product (DP), Clinical Material:
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    1 Jun 2022, 12:36 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 1 Jun 2022, 00:00 BST · £1,072,764
Commercial outcome and competition
Awards
ADVENT SRL
Not published · Not published · active
Contracts
Contract
£1,072,764 · signed 1 Jun 2022, 00:00 BST · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

UNIVERSITY OF YORK

Contracting authority GB-FTS-29918
View buyer profile

  • UNIVERSITY OF YORK
    buyer

    Heslington, YORK, UKE21, YO105DD
    procurement@york.ac.uk
    +44 1904328201

  • ADVENT SRL
    supplier

    Via Pontina km 30,600 00071 Pomezia (RM), Pomezia, IT

  • Royal Courts of Justice
    reviewBody

    Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe University of York (including its associated entities) intends to contract with the enclosed provider for the manufacture of a vaccine clinical lot for a 42 month period commencing 1st July 2022 without a call for competition. The University's reasons are: • The clinical lot is required to be compatible in manufacture with that previously used in clinical trials by the University of York, requiring manufacture using the cell line "Procell 92". The contractor were co-designers of the vaccine used in the clinical trials. • Only the contractor is authorised by the owners of Procell 92 (GSK) to use this cell line for manufacture of a Leishmaniasis vaccine